Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Ruberg

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The American Journal of Cardiology|August 14, 1987
Biotransformation and pharmacokinetic overview of enoximone and its sulfoxide metaboliteR A Okerholm, K Y Chan, J F Lang, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1990
Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome"J Sahai, D P Healy, M J Shelton, et al.
Journal of Clinical Pharmacology|March 1, 1992
Pharmacokinetics of terfenadine in healthy elderly subjectsM G Eller, B J Walker, P A Westmark, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1992
Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteersJ A Smithers, H K Kulmala, G A Thompson, et al.
Biopharmaceutics & Drug Disposition|November 1, 1992
Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1J A Smithers, G A Thompson, M T Kenny, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The American Journal of Cardiology|August 14, 1987
Biotransformation and pharmacokinetic overview of enoximone and its sulfoxide metaboliteR A Okerholm, K Y Chan, J F Lang, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1990
Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome"J Sahai, D P Healy, M J Shelton, et al.
Journal of Clinical Pharmacology|March 1, 1992
Pharmacokinetics of terfenadine in healthy elderly subjectsM G Eller, B J Walker, P A Westmark, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1992
Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteersJ A Smithers, H K Kulmala, G A Thompson, et al.
Biopharmaceutics & Drug Disposition|November 1, 1992
Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1J A Smithers, G A Thompson, M T Kenny, et al.
Pageof 2